Title: Incidence and clinical profile of Triple negative breast cancer in Kashmir
Authors: Wani Shahid Bashir, Shah Saqib Ahmad, Lone Mansoor, Sofi Mushtaq Ahmad, Najmi Arshad Manzoor, Teli Mohd. Ashraf, Sheikh Aejaz Aziz, Lone Mohd. Maqbool, Afroz Fir
DOI: https://dx.doi.org/10.18535/jmscr/v5i4.162
Abstract
Introduction
Breast cancer is a heterogenous disease, encompassing a plethora of entities which not only have distinct morphological features but also clinical behaviour. In recent years it has become apparent that this diversity may be underpinned by distinct patterns of genetic, epigenetic and transcriptomic abberations1.
Tiple negative breast cancer (TNBC) is defined by a lack of expression of both estrogen and progesterone receptors as well as human epidermal growth factor receptor-2. It is charecterised by distinct molecular, histological and clinical features including a particularly unfavourable prognosis despite increased sensit-ivity to standard cytotoxic chemotherapy regimes.
The epidemiological risk factors of TNBC compared to non TNBC appear to differ significantly. Overall, the prevalence of TNBC in large unselected breast cancer patient cohorts is 11-20%[2,3], whereas in selected cohorts of patients with advanced breast cancer or patients of African-American ethnicity, TNBC may be diagnosed among as many as 23-28% of all patients[4,5] and in Asian populations upto 25-31%.6
